FDA fast-tracks Island Pharmaceuticals' Marburg antiviral pathway
The US Food & Drug Administration confirmed a streamlined development pathway for Galidesivir.
The US Food & Drug Administration confirmed a streamlined development pathway for Galidesivir.
Australia's new vehicle market has demonstrated remarkable resilience at the start of 2026, recording 87,092 sales in January.
Jumbo Interactive (ASX:JIN) has signaled a robust start to the 2026 fiscal year, reporting a preliminary underlying group EBITDA of $37.5 million for the first half.
Abacus Group (ASX:ABG) and Abacus Storage King (ASX:ASK) have commenced preliminary discussions regarding a potential proposal to internalise the management functions of the storage giant.
Amcor (ASX:AMC), the global titan of consumer packaging, has reaffirmed its full-year outlook following a robust half-year performance bolstered by its $13 billion acquisition of US-based Berry Global.
Nova Minerals (ASX:NVA) revealed plans to redomicile the company from Australia to the United States.
Charter Hall Social Infrastructure REIT (ASX:CQE) has reported a statutory profit of $47 million for the first half of FY26
Dairy processor Synlait Milk (ASX:SM1) has issued a financial update, forecasting a significant net loss for the first half of the 2026 financial year as it undergoes a massive structural "reset."
Pinnacle Investment Management (ASX:PNI) reported an 11% decline in first-half net profit and signed a definitive agreement to acquire the remaining 79.2% stake in Pacific Asset Management.
Global electric vehicle pioneer Vmoto (ASX:VMT) has signaled a turnaround in its latest market update, reporting a 68.3% leap in sales for the final quarter of 2025.
AustralianSuper, the nation's largest pension fund, has reduced its position in the ASX (ASX:ASX).
The Reserve Bank of Australia has lifted the cash rate 25 basis points to 3.85%, its first hike in nearly two years, jolting borrowers and markets.